Pluri (NASDAQ:PLUR) Announces Earnings Results

Pluri (NASDAQ:PLUR) announced its earnings results on Tuesday. The company reported ($0.53) earnings per share for the quarter, Zacks reports. Pluri had a negative net margin of 4,184.28% and a negative return on equity of 917.18%.

Pluri Price Performance

Shares of PLUR stock traded up $0.03 during trading hours on Tuesday, hitting $4.33. 4,142 shares of the company’s stock were exchanged, compared to its average volume of 13,152. The company has a market capitalization of $24.07 million, a PE ratio of -0.72 and a beta of 1.67. Pluri has a 12-month low of $4.07 and a 12-month high of $8.48. The business’s 50 day simple moving average is $4.53 and its 200-day simple moving average is $4.99. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.